News – Page 347 – Endpoints News

House committee takes on PBMs as bipartisan support for wider reforms grows

3 years ago

MarketingRx roundup: Moderna, Pfizer, J&J top pharmas on innovation list; Bristol Myers taps IPG for media

3 years ago

Weight loss field expands as Pfizer's oral GLP-1 gathers comparisons to Novo's Wegovy in PhII data

3 years ago

FDA grants an expanded Ayvakit label to Blueprint Medicines

3 years ago

Affimed lays off around 50 staffers as it brings combo NK cell therapy to PhII

3 years ago

An early-stage fail highlights ongoing ALS drug development challenges, despite recent Biogen OK

3 years ago

PhIII win for smoking cessation treatment puts Achieve Life Sciences on path to FDA, jazzes up deal talks

3 years ago

CohBar, Morphogenesis link up in reverse merger of two cancer biotechs

3 years ago

Larkspur Biosciences kicks off with $30M+, hunting for new oncology immunotherapies

3 years ago

Who else wanted to buy Iveric? Before the $5.9B Astellas deal, five biopharma companies took a look

3 years ago

In wake of Rubius downfall, a new biotech spinout launches to 'take the next step' in red blood cell therapies

3 years ago

Icosavax pushes forward combo RSV-hMPV vaccine and announces direct stock offering

3 years ago

FDA approves another new type of opioid overdose antidote nasal spray

3 years ago

Back Bay makes deal with Norway's DNB in banking and advisory partnership

3 years ago

Roche scraps second mid-stage schizophrenia trial in as many years

3 years ago

Amit Munshi has more than $300M and a startup CSO out to pioneer next-gen RNA therapeutics. Once again, he’s ...

3 years ago

One-fifth of late-stage cancer trials changed primary endpoints after trial start, JAMA Network Open study says

3 years ago

Government-backed pilots investigate how tech can better secure the drug supply chain

3 years ago

FDA plans to only issue pediatric exclusivity for new studies — not just those required under PREA

3 years ago

Americans may not understand survival nuances in cancer brand commercials, FDA research finds

3 years ago

Novo Nordisk says oral version of Wegovy also works at reducing weight in a PhIII study

3 years ago

Exclusive: Sanofi's CEO Paul Hudson talks pipeline, M&A, insulin hearings and Dupixent

3 years ago

Krystal Biotech raises $160M via PIPE on heels of FDA approval for gene therapy

3 years ago

As it awaits key readout, Hepion boosts confidence in NASH drug hopeful via shorter study

3 years ago

First page Previous page 344 345 346347348 349 350 Next page Last page